Myositis is an inflammatory disease of muscle tissue that can affect individual muscle groups or spread to the entire skeletal muscle. Myositis can be caused by infectious agents, autoimmune processes, injuries, or chemical exposure. The disease is characterized by increased muscle sensitivity, weakness, pain syndromes, and may also be accompanied by systemic symptoms such as fever and fatigue. Forms of myositis include dermatomyositis, polymyositis, and necrotizing myositis, each with its own clinical and pathophysiological features.
History of the disease and interesting historical facts
The history of myositis goes back many centuries, beginning with descriptions of symptoms similar to modern manifestations in medical texts from Ancient Egypt and Greece. In the 19th century, with the development of pathomorphology, doctors began to associate inflammation of muscle tissue with other diseases, such as tuberculosis. Scientific research in the early 20th century led to the identification of separate forms of myositis, such as dermatomyositis, which opened up new horizons in understanding and treating this disease. The advent of specialized diagnostic methods, such as MRI and CT, has significantly improved the accuracy of myositis diagnostics and understanding of its pathogenesis.
Epidemiology
Epidemiological studies show that myositis is relatively rare, with an average incidence of 1 to 10 cases per 100,000 people. Dermatomyositis predominantly affects women aged 40 to 60 years, while polymyositis can occur in men and women over a wider age range. In addition, myositis can be secretory in nature, with cases of the disease being more common in people with a predisposition to autoimmune diseases.
Genetic predisposition to this disease
Genetic studies suggest that myositis may be associated with specific genes and mutations. The main genes involved include HLA-DRB1, which is associated with increased susceptibility to autoimmune diseases, as well as genes responsible for the immune response, such as CTLA-4 and PTPN22. Common mutations may contribute to dysregulation of the immune system, which may lead to activation of the inflammatory process in the muscles. Specific genetic markers may serve as indicators for the diagnosis and prognosis of myositis.
Risk factors for the development of this disease
There are several known risk factors that contribute to the development of myositis. These include:
- Infectious factors: viral infections (Epstein-Barr virus, influenza virus)
- Chemical exposure: long-term exposure to toxic substances (asbestos, pesticides)
- Immune disorders: presence of other autoimmune diseases (eg, systemic lupus erythematosus)
- Age: Myositis is more common in middle-aged and older people.
- Gender: Women are more at risk than men
Diagnosis of this disease
Diagnosis of myositis is based on clinical symptoms and laboratory test results. The main symptoms include:
- Muscle weakness
- Pain and discomfort in the affected muscles
- Swelling and/or redness.
Laboratory tests may include:
- Blood tests for creatine kinase (CK) and myoglobin levels
- Antibody tests (eg, anti-Jo-1)
- Muscle biopsy to confirm the diagnosis.
Radiological examinations such as MRI can reveal changes in muscle tissue and assess the extent of the inflammatory process. An important step is differential diagnosis, which includes excluding diseases with similar symptoms, such as infectious myositis or muscular dystrophy.
Treatment
Treatment of myositis should be individualized depending on the form of the disease and its severity. General approaches may include:
- Corticosteroids to reduce inflammation
- Immunosuppressants such as methotrexate or azathioprine
- Physiotherapy to improve muscle function.
Pharmacological treatment is usually aimed at suppressing the inflammatory process. In severe cases, surgery may be required, for example in the presence of abscesses or severe muscle atrophy. New methods are also being investigated, including the use of biologic drugs to treat autoimmune processes.
List of medications used to treat this disease
- Prednisolone
- Methotrexate
- Azathioprine
- Rituximab
- Mycophenolate mofetil
Disease monitoring
Myositis monitoring includes regular follow-up examinations to assess the effectiveness of treatment and the dynamics of the disease. Important monitoring stages:
- Checking creatine kinase levels and other inflammation markers
- Assessment of the functional state of muscles
- Regular biopsy if changes in treatment are needed
The prognosis of myositis depends on the form of the disease and the time of treatment. Possible complications may include progression of muscle weakness and the risk of chronic disability.
Age-related features of the disease
Myositis can manifest itself differently in different age groups. Children are more likely to have dermatomyositis, which manifests itself as characteristic skin rashes. Adults are more likely to have polymyositis, which can be more aggressive. In older patients, the disease may have less pronounced symptoms, which makes diagnosis and treatment more difficult.
Questions and Answers
- What is myositis and its main symptoms? Myositis is an inflammation of muscle tissue that causes weakness, pain and discomfort in the muscles.
- What are the main causes of myositis? Underlying causes include infections, autoimmune disorders, trauma, and chemical exposures.
- How is myositis diagnosed? Diagnosis is based on clinical symptoms, laboratory tests, muscle biopsy and radiological studies.
- What treatments are used for myositis? Treatment includes corticosteroids, immunosuppressants, physical therapy and, in severe cases, surgery.
- What is the prognosis for patients with myositis? The prognosis depends on the timeliness of diagnosis and adequacy of treatment; complications can lead to impaired muscle function.
